574662 Survivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₂₀H₁₉BrN₄O₃ 781661-94-7

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
574662-10MG
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA cell-permeable imidazolium derivative that suppresses survivin expression, blocks survivin promoter activity, and induces apoptosis in a variety of tumor cell lines (IC50 = 540nM) in a dose-dependent manner. The main target of YM155 appears to be the interleukin enhancer-binding factor 3 (ILF3/NF110) with shorter C-terminal lengths associated with reduced binding. Exhibits potent anti-tumor effects without any severe systemic toxicity in murine models. Reported to induce tumor regression by suppressing intratumor survivin levels in PC3-xenograph tumor models (by 47% and 80% at 1 and 5 mg/kg, respectively.
      Catalogue Number574662
      Brand Family Calbiochem®
      SynonymsSurvivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor
      References
      ReferencesNakamura, N., et al. 2012. Mol. Cell. Proteomics. 11, M111.0132434.
      Tolcher, A.W., et al. 2008, J. Clin. Oncol. 26, 5198.
      Nakahara, T., et al. 2007, Cancer Res. 67, 8014.
      Product Information
      CAS number781661-94-7
      FormYellow solid
      Hill FormulaC₂₀H₁₉BrN₄O₃
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Target Interleukin enhancer-binding factor 3 (ILF3/NF110)
      Primary Target IC<sub>50</sub>540nM
      Secondary targetUnknown
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Survivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Survivin Inhibitor, YM155 - CAS 781661-94-7 - Calbiochem Certificates of Analysis

      TitleLot Number
      574662

      References

      Reference overview
      Nakamura, N., et al. 2012. Mol. Cell. Proteomics. 11, M111.0132434.
      Tolcher, A.W., et al. 2008, J. Clin. Oncol. 26, 5198.
      Nakahara, T., et al. 2007, Cancer Res. 67, 8014.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-March-2017 JSW
      SynonymsSurvivin Inhibitor I, Interleukin Enhancer-Binding Factor 3 Inhibitor
      DescriptionA cell-permeable imidazolium derivative that suppresses survivin expression, blocks survivin promoter activity, and induces apoptosis in a variety of tumor cell lines (IC50 = 540nM) in a dose-dependent manner. The main target of YM155 appears to be the interleukin enhancer-binding factor 3 (ILF3/NF110) with shorter C-terminal lengths associated with reduced binding. Exhibits potent anti-tumor effects without any severe systemic toxicity in murine models. Reported to induce tumor regression by suppressing intratumor survivin levels in PC3-xenograph tumor models (by 47% and 80% at 1 and 5 mg/kg, respectively.
      FormYellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number781661-94-7
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (50 mg/ml)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesNakamura, N., et al. 2012. Mol. Cell. Proteomics. 11, M111.0132434.
      Tolcher, A.W., et al. 2008, J. Clin. Oncol. 26, 5198.
      Nakahara, T., et al. 2007, Cancer Res. 67, 8014.